ArgonautArgonautArgonautArgonaut
  • About Us
    • Business Model
    • Regulation
    • Community
    • Jason and the Argonauts
    • Disclaimer and Disclosure
    • COVID-19 Visitor Requirements
  • Corporate Finance
  • Stockbroking & Research
    • Stockbroking
    • Research
    • Best Execution Policy
    • Administration Forms
    • Open an Account
  • Special Situations
  • News
    • Latest News
    • Morning Notes
    • Latest Research
  • Contact
    • Careers
      • Advisers
      • Graduate Program
      • Internship Program

Botanix (BOT) – Positive BTX 1801 Study Results

    Home Latest Research Botanix (BOT) – Positive BTX 1801 Study Results
    NextPrevious

    Botanix (BOT) – Positive BTX 1801 Study Results

    By Wendy McEvoy | Latest Research, Uncategorized | 0 comment | 4 February, 2021 | 0

    BOT announced positive results from its BTX 1801 Phase 2a nasal decolonisation proof of concept study.  We upgrade to SPEC BUY (prior HOLD) as these results highlight CBD’s potential as a new treatment for resistant bacteria.

    To access the full report please log in under the Client Area at the bottom of this page.

    Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.

    If you would like to access our research please contact us to create an account.

    No tags.

    Related Posts

    • Gage Roads (GRB) – Can Do Attitude

      By Wendy McEvoy | 0 comment

      The success of a small-scale trial with cans has encouraged GRB to invest $7.8m in a full-scale can filler, an upgraded bottle filler, and other site improvements.  Costs will largely be met by an equityRead more

    • 15/03/2023 – Morning Note

      By Jonas Dorling | 0 comment

      Key News Overnight: U.S. stocks bounced back on Tuesday as largely on-target inflation data and easing jitters over contagion in the banking sector cooled expectations regarding the size of the rate hike at the FederalRead more

    • New Research – Sovereign Metals (SVM) – Kasiya Site Visit Insights

      By Wendy McEvoy | 0 comment

      We recently visited Sovereign Metals’ (SVM) giant Kasiya rutile and graphite project in Malawi. Development of Kasiya would be transformational for both SVM and the nation. Beyond the immediate financial benefits, Malawi would become aRead more

    • New Research – Global Lithium – Manna Study Dissection

      By Wendy McEvoy | 0 comment

      GL1 has reported the results of a Scoping Study for the Company’s flagship Manna project. While the study’s financial model generates an impressive Pre-tax NPV, in our view, the use of US$2,500/t sale price forRead more

    • Red 5 Ltd (RED) – # Reportcredits

      By Wendy McEvoy | 0 comment

      We have had to go back and revise up our expenditure estimates again. Sell recommendation retained. To access the full report please log in under the Client Area at the bottom of this page.  Argonaut’sRead more

    NextPrevious

    Recent Posts

    • 20/03/2023 – Morning Note
    • 17/03/2023 – Morning Note
    • 16/03/2023 – Morning note
    • Acquisition of Vango Mining by Catalyst Metals marks the first step to controlling a third highly prospective Australian gold belt
    • 15/03/2023 – Morning Note

    Archives

    • About Us
      • Business Model
      • Regulation
      • Community
      • Jason and the Argonauts
      • Disclaimer and Disclosure
      • COVID-19 Visitor Requirements
    • Corporate Finance
    • Stockbroking & Research
      • Stockbroking
      • Research
      • Best Execution Policy
      • Administration Forms
      • Open an Account
    • Special Situations
    • News
      • Latest News
      • Morning Notes
      • Latest Research
    • Contact
      • Careers
        • Advisers
        • Graduate Program
        • Internship Program
    Argonaut

    Argonaut | The Natural Choice in Resources.
    © 2022 Argonaut.

    Corporate Finance
    Stockbroking & Research
    Contact Us

    Argonaut | Perth

    Level 30, Allendale Square, 77 St Georges Terrace Perth, WA, 6000 Australia

    clientservices@argonaut.com

    ABN 72 108 330 650

    Argonaut | Login

    Client Area Help
    Register for Access to Client Area
    Privacy Policy
    Financial Services Guide 
    Website Disclaimer

    Copyright 2022 | Website ⚡ by Start Digital